Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Steatohepatitis NASH”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02696941
What this trial is testing

SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Oxford 20
Not applicableActive Not RecruitingNCT06011356
What this trial is testing

Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study

Who this might be right for
Cardiovascular DiseasesNon-Alcoholic Fatty Liver DiseaseRespiratory Disease+1 more
Imperial College London 1,000
Not applicableStudy completedNCT02018237
What this trial is testing

High Fructose Corn Syrup

Who this might be right for
Nonalcoholic Fatty Liver DiseaseObesity
Washington University School of Medicine 47
Testing effectiveness (Phase 2)Study completedNCT04031729
What this trial is testing

Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Massachusetts General Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT05984745
What this trial is testing

Effect of CoQ10 on the Outcome of MAFLD Patients

Who this might be right for
Fatty LiverNAFLD
Ain Shams University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05480696
What this trial is testing

Soluble Fibre Supplementation in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisHepatic Steatosis
McMaster University 60
Early research (Phase 1)Study completedNCT04812262
What this trial is testing

DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Who this might be right for
Overweight and ObesityType2 DiabetesNAFLD
Neuraly, Inc. 255
Not applicableStudy completedNCT06398522
What this trial is testing

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

Who this might be right for
NAFLDMetabolic Syndrome
University of Bologna 50
Large-scale testing (Phase 3)UnknownNCT02654665
What this trial is testing

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Weight LossNon-alcoholic Steatohepatitis (NASH)
Changi General Hospital 36
Large-scale testing (Phase 3)Study completedNCT01992809
What this trial is testing

Omega 3 Supplementation in Fatty Liver

Who this might be right for
Fatty Liver
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT07730905
What this trial is testing

Analysis of Renal Impairment Characteristics and High-Risk Factors in Chronic Hepatitis B Patients on Long-Term Oral Nucleos(t)Ide Analogues

Who this might be right for
Non-alcoholic Fatty Liver Disease, Renal Function Impairment
Foshan Hospital of Traditional Chinese Medicine 300
Testing effectiveness (Phase 2)Study completedNCT04773964
What this trial is testing

Study to Evaluate MET642 in Patients With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Metacrine, Inc. 215
Testing effectiveness (Phase 2)Study completedNCT01571063
What this trial is testing

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
University of Zurich 22
Large-scale testing (Phase 3)Study completedNCT01051219
What this trial is testing

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

Who this might be right for
Nonalcoholic Steatohepatitis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Not applicableEnded earlyNCT04440540
What this trial is testing

Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

Who this might be right for
Non-alcoholic Fatty Liver Disease
Chinese University of Hong Kong 10
Not applicableActive Not RecruitingNCT06888310
What this trial is testing

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

Who this might be right for
NASHNAFLD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 408
Not applicableStudy completedNCT05081427
What this trial is testing

Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

Who this might be right for
Nonalcoholic Fatty Liver
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT04134091
What this trial is testing

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc. 56
Not applicableStudy completedNCT03897218
What this trial is testing

Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health"

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
RWTH Aachen University 84
Not applicableUnknownNCT05106049
What this trial is testing

Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Assiut University 90
Next Page